Inactive
Notice ID:75N95021R00061
PRESOLICITATION NOTICE OF INTENT NON-COMPETITIVE INTRODUCTION PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT ACTION. THIS I...
PRESOLICITATION NOTICE OF INTENT NON-COMPETITIVE INTRODUCTION PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT ACTION. THIS IS A PRE-SOLICITATION NON-COMPETITIVE NOTICE OF INTENT TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), NIDA Office of Acquisition – NCATS Section, on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a contract or purchase order without providing for full and open competition (including brand-name) to: Regenstrief Institute, Inc. 1101 West 10th Street Indianapolis, IN 46202 for a follow-on contract to provide linkage honest broker services in support of the National COVID Cohort Collaborative (N3C). NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541519, Other Computer-Related Services, with a size standard of $30.0 million. REGULATORY AUTHORITY This acquisition is conducted under the authority of Federal Acquisition Regulation (FAR) subpart 13.5, Simplified Procedures for Certain Commercial Items, and FAR 13.106(b)(1), Soliciting from a single source. The resulting contract will include all applicable provisions and clauses of the FAR in effect through Federal Acquisition Circular (FAC) 2021-06 (7/12/2021). STATUTORY AUTHORITY This acquisition is conducted as non-competitive using the procedures of FAR subpart 13.5 in accordance with 41 U.S.C. 1903. DESCRIPTION OF REQUIREMENT Purchase Description Linkage honest broker services to the National COVID Cohort Collaborative (N3C) Purpose and Objectives The National COVID-19 Cohort Collaborative (N3C) sponsors the NIH COVID-19 Data Enclave, https://covid.cd2h.org/, one of the largest data enclaves in the world supporting COVID-19 research. N3C is a partnership among the NCATS-supported Clinical and Translational Science Awards (CTSA) Program hubs, the National center for Data to Health (CD2H), and the NIGMS-supported Institutional Development Award Networks for Clinical and Translational Research (IDeA-CTR). The N3C Data Enclave is a secure platform storing harmonized clinical data provided by more than 50 contributing members. The Enclave hosts over 651 million clinical observations on over 6.5 million persons, including over 2.1 million COVID cases. The Enclave stores over 7.3 billion rows of data. Harmonization, anonymity, and security is accomplished through the N3C privacy-preserving record linkage (PPRL). The PPRL uses a de-identified software-generated token applied by a data contributor to each patient record. The linkage honest broker holds the de-identified tokens and provides a service matching tokens generated across disparate data sets without knowledge of the identity of the patients.The de-identified tokens are held separately from data residing within the data enclave. The linkage honest broker function is critical to the PPRL, which in turn is critical to continued use of the N3C Data Enclave by researchers. The salient characteristic of this requirement that reasonably limits it to one source is the incumbent vendor’s ability to provide uninterrupted linkage honest broker support (harmonization, anonymity, and security) for the N3C Data Enclave established pursuant to the Public Health Emergency declaration made January 31, 2020, and the National Emergency declaration made March 13, 2020. Period of Performance This action is anticipated to be an indefinite delivery, indefinite quantity contract with an ordering period of 9/29/2021 – 9/28/2023. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. Responses to this notice must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations. In addition the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by 11:00 a.m. Eastern time on August 30, 2021, and reference notice no. 75N95021R00061. Responses must be submitted by email to Stuart Kern, Contract Specialist, stuart.kern@nih.gov.
